SCHEMBL5316644

SCHEMBL5316644

NC(=O)c1cnc(-c2ccccc2)nc1N(c1ccccc1)c1ccnc(NCCc2cccnc2)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK3 P52333 2/20 0.43
STAT6 P42226 4/20 0.41
MKNK1 Q9BUB5 1/20 0.40
MKNK2 Q9HBH9 1/20 0.40
GBA1 P04062 1/20 0.38
OGA O60502 1/20 0.38
JAK2 O60674 1/20 0.38
JAK1 P23458 1/20 0.38
NAMPT P43490 2/20 0.38
TYRO3 Q06418 1/20 0.37
SGK1 O00141 1/20 0.37
ROCK2 O75116 1/20 0.37
RPS6KA5 O75582 1/20 0.37
RAF1 P04049 1/20 0.37
SRC P12931 1/20 0.37
CCNA2 P20248 1/20 0.37
CDK2 P24941 1/20 0.37
MAPK8 P45983 1/20 0.37
MAPK9 P45984 1/20 0.37
BLK P51451 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5264926 0.89 STAT6 (0.44) JAK3STAT6MKNK1MKNK2GBA1
SCHEMBL5261679 0.79 PDE4B (0.50) JAK3STAT6GBA1JAK2JAK1
SCHEMBL5914124 0.75 OGA (0.48) MKNK1MKNK2GBA1OGACCNA2
SCHEMBL5914225 0.75 JAK3 (0.54) JAK3STAT6JAK2JAK1TYRO3
SCHEMBL5914085 0.71 PDE4B (0.52) JAK3STAT6MKNK1MKNK2GBA1
SCHEMBL5913970 0.70 GBA1 (0.45) MKNK1MKNK2GBA1OGA
SCHEMBL5262434 0.69 GBA1 (0.42) MKNK1MKNK2GBA1OGACCNA2
SCHEMBL5263806 0.67 MAPK14 (0.42) MAPK14
SCHEMBL5913967 0.67 HTR7 (0.48) MKNK1MKNK2OGACCNA2CDK2
SCHEMBL5914395 0.66 CYP1A2 (0.55) MKNK1MKNK2GBA1OGACCNA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1794135-A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS AND METHODS OF USE Amgen Inc. (US) 2007-06-13 EP claimed
WO-2006037117-A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS AND METHODS OF USE AMGEN INC. (US) 2006-04-06 WO claimed